Kura Price Book Value Ratio from 2010 to 2024
| KURA Stock | USD 21.68 0.77 3.68% |
Price Book Value Ratio | First Reported 2010-12-31 | Previous Quarter 2.65065338 | Current Value 2.78 | Quarterly Volatility 1.1 K |
Check Kura Oncology financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Kura main balance sheet or income statement drivers, such as Other Operating Expenses of 174.1 M, Total Operating Expenses of 173.2 M or Interest Expense of 1.6 M, as well as many exotic indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 2.78. Kura financial statements analysis is a perfect complement when working with Kura Oncology Valuation or Volatility modules.
Kura | Price Book Value Ratio |
Latest Kura Oncology's Price Book Value Ratio Growth Pattern
Below is the plot of the Price Book Value Ratio of Kura Oncology over the last few years. It is Kura Oncology's Price Book Value Ratio historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Kura Oncology's overall financial position and show how it may be relating to other accounts over time.
| Price Book Value Ratio | 10 Years Trend |
|
Price Book Value Ratio |
| Timeline |
Kura Price Book Value Ratio Regression Statistics
| Arithmetic Mean | (439.54) | |
| Geometric Mean | 16.20 | |
| Coefficient Of Variation | (239.95) | |
| Mean Deviation | 635.87 | |
| Median | (2.71) | |
| Standard Deviation | 1,055 | |
| Sample Variance | 1.1M | |
| Range | 4K | |
| R-Value | 0.63 | |
| Mean Square Error | 727,480 | |
| R-Squared | 0.39 | |
| Significance | 0.01 | |
| Slope | 147.78 | |
| Total Sum of Squares | 15.6M |
Kura Price Book Value Ratio History
About Kura Oncology Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Kura Oncology income statement, its balance sheet, and the statement of cash flows. Kura Oncology investors use historical funamental indicators, such as Kura Oncology's Price Book Value Ratio, to determine how well the company is positioned to perform in the future. Although Kura Oncology investors may use each financial statement separately, they are all related. The changes in Kura Oncology's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Kura Oncology's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Kura Oncology Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Kura Oncology. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Price Book Value Ratio | 2.65 | 2.78 |
Kura Oncology Investors Sentiment
The influence of Kura Oncology's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Kura. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to Kura Oncology's public news can be used to forecast risks associated with an investment in Kura. The trend in average sentiment can be used to explain how an investor holding Kura can time the market purely based on public headlines and social activities around Kura Oncology. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Kura Oncology's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Kura Oncology's and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Kura Oncology's news discussions. The higher the estimated score, the more favorable is the investor's outlook on Kura Oncology.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Kura Oncology in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Kura Oncology's short interest history, or implied volatility extrapolated from Kura Oncology options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out the analysis of Kura Oncology Correlation against competitors. For information on how to trade Kura Stock refer to our How to Trade Kura Stock guide.You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.
Complementary Tools for Kura Stock analysis
When running Kura Oncology's price analysis, check to measure Kura Oncology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Kura Oncology is operating at the current time. Most of Kura Oncology's value examination focuses on studying past and present price action to predict the probability of Kura Oncology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Kura Oncology's price. Additionally, you may evaluate how the addition of Kura Oncology to your portfolios can decrease your overall portfolio volatility.
| Transaction History View history of all your transactions and understand their impact on performance | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios |
Is Kura Oncology's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Kura Oncology. If investors know Kura will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Kura Oncology listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.17) | Return On Assets (0.23) | Return On Equity (0.37) |
The market value of Kura Oncology is measured differently than its book value, which is the value of Kura that is recorded on the company's balance sheet. Investors also form their own opinion of Kura Oncology's value that differs from its market value or its book value, called intrinsic value, which is Kura Oncology's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Kura Oncology's market value can be influenced by many factors that don't directly affect Kura Oncology's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Kura Oncology's value and its price as these two are different measures arrived at by different means. Investors typically determine if Kura Oncology is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Kura Oncology's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.